BALTIMORE, Aug. 1, 2024
/PRNewswire/ -- University of Maryland School
of Medicine (UMSOM) Dean Mark T. Gladwin, MD, announced today
that R. Frank Henn, III,
MD, Professor of Orthopaedics, who has served as Interim Chair
of the Department since 2022, has been appointed to serve as the
new Chair of UMSOM's Department of Orthopaedics, effective
immediately.
Dr. Henn, who joined the Department in 2010, is an academic
leader and highly regarded, board-certified orthopaedic surgeon; he
has published significant scientific research, and is a leading
clinician focusing on the care of the shoulder and knee, with an
emphasis in cartilage restoration and joint repair techniques.
"Dr. Henn has an outstanding track record of success in
scientific research, clinical care, and education," said
Dean Gladwin who is also the John Z.
and Akiko K. Bowers Distinguished Professor at UMSOM and Vice
President for Medical Affairs at the University of Maryland, Baltimore. "He has
already made a significant impact with his contributions to
research in knee injury and patient outcomes and his clinical
expertise in complex reconstruction of the shoulder and knee, as
well as his experience building a nationally recognized residency
program. Dr. Henn is well suited to lead the Department as
Chair."
Dr. Henn is actively engaged in research efforts, most recently
as the Principal Investigator of the "Outcomes of Multi-ligament
Knee Injuries" study funded by the Foundation for Orthopedic
Trauma, and the "Maryland Orthopaedic and Sports Medicine Research
Registry" study funded by a Kernan Endowment grant.
He has published 120 peer-reviewed scientific papers with a
focus on patients' expectations, satisfaction, and surgical
outcomes. These include six studies regarding Press-Ganey patient
satisfaction surveys after orthopaedic surgery. His paper published
in the Journal of Bone and Joint Surgery in 2021
demonstrated significant disparities in patient populations that
complete patient satisfaction surveys, raising concerns that
response bias may limit interpretation of survey results. He also
has developed a new metric for assessing patient-based outcomes
that involves asking patients if they are 'completely better' after
orthopaedic surgery. The first study using this metric after ACL
reconstruction was published in the American Journal of
Sports Medicine in 2022. He also co-led the CARE
randomized trial which found that counseling significantly reduced
opioid utilization after ACL reconstruction without compromising
pain control or sleep.
Dr. Henn's exemplary leadership as the Department's Residency
Director since 2013 has resulted in that program's present
recognition as one of the top orthopaedic residencies in the
nation. "We have a reputation for training outstanding
surgeons who have many opportunities for achievement in clinical
care, research, and mentorship," said Dr. Henn. In 2023,
the program had more than 800 applicants vying for just six
resident positions. Dr. Henn also introduced a formal resident
research curriculum in 2017 that has produced significant results,
with resident publications in recognized scientific journals
increasing over the past five years, and two residents awarded a
research grant from the Orthopaedic Research and Education
Foundation (OREF), a leading resource for new investigators.
Clinically, he is highly experienced in the field of sports
medicine. Dr. Henn has served as a physician for a number of
prominent professional and collegiate sports teams, including the
New England Patriots, Boston Bruins, Boston Red Sox, and currently
serves as a team orthopaedic surgeon for the UMBC Retrievers,
University of Maryland Terrapins, and
the Baltimore Nighthawks.
Under Dr. Henn's leadership as Interim Chair, the Department of
Orthopaedics at UMSOM continued to make important advances,
including establishing new clinical sites, expanding the faculty,
increasing market share, improving quality metrics, and growing
educational programs. The Department is now among the nation's top
12 programs for annual federal and private research funding and
recently set worldwide practice standards in clinical
investigations by leading two of the largest orthopaedic trauma
trials ever conducted. The PREPARE trial enrolled over 8,000
patients and showed that skin antisepsis with iodine povacrylex
resulted in significantly fewer surgical site infections than
chlorhexidine after surgery for closed extremity fractures and was
published in the New England Journal of
Medicine this year. The PREVENT-CLOT trial was published
in the New England Journal of Medicine in 2023 and
demonstrated that aspirin was non-inferior to low molecular weight
heparin in preventing death and pulmonary embolism in over 12,000
patients with pelvic/acetabular fractures or surgical extremity
fractures.
Dr. Henn has been recognized by Baltimore
Magazine as a "Top Doctor" for seven consecutive years,
starting in 2017, and also has been honored with the Neer Award in
Clinical Science from the American Shoulder and Elbow Surgeons, and
the Achilles Research Award from the International Society of
Arthroscopy, Knee Surgery and Orthopaedic Sports Medicine (ISAKOS).
He is currently an active member of the Orthopaedic Research
Society, the American Orthopaedic Society for Sports Medicine,
American Orthopaedic Association, as well as a Fellow of the
American Orthopaedic Association, among others.
After earning his medical degree at Brown
University, Dr. Henn completed his internship in General
Surgery at New York Presbyterian Hospital, Cornell, followed by a residency in orthopaedic
surgery at the Hospital for Special Surgery (NYC), and fellowships
in Sports Medicine at Massachusetts
General Hospital, and at the Cartilage Repair Center at Brigham
& Women's Hospital (Boston).
"It is an honor to have the opportunity to lead this
distinguished department, and I look forward to building on our
consistent growth and success," said Dr. Henn. "My
goals are to expand access to outstanding interdisciplinary
musculoskeletal care, grow our exceptional research program, and
provide optimal educational experiences for students and
trainees."
About the University of Maryland School of
Medicine:
Now in its third century, the University of
Maryland School of Medicine was chartered in 1807 as the
first public medical school in the United
States. It continues today as one of the fastest growing,
top-tier biomedical research enterprises in the world -- with 46
academic departments, centers, institutes, and programs, and a
faculty of more than 3,000 physicians, scientists, and allied
health professionals, including members of the National Academy of
Medicine and the National Academy of Sciences, and a distinguished
two-time winner of the Albert E.
Lasker Award in Medical Research. With an operating budget
of more than $1.2 billion, the School
of Medicine works closely in partnership with the University of Maryland Medical Center and Medical
System to provide research-intensive, academic and clinically based
care for nearly 2 million patients each year. The School of
Medicine has nearly $600 million in
extramural funding, with most of its academic departments highly
ranked among all medical schools in the nation in research funding.
As one of the seven professional schools that make up the
University of Maryland, Baltimore
campus, the School of Medicine has a total population of
nearly 9,000 faculty and staff, including 2,500 students, trainees,
residents, and fellows. The combined School of Medicine and Medical
System ("University of Maryland
Medicine") has an annual budget of over $6
billion and an economic impact of nearly $20 billion on the state and local community. The
School of Medicine, which ranks as the 8th highest among public
medical schools in research productivity (according to the
Association of American Medical Colleges profile) is an innovator
in translational medicine, with 606 active patents and 52 start-up
companies. In the latest U.S. News & World Report ranking of
the Best Medical Schools, published in 2021, the UM School of
Medicine is ranked #9 among the 92 public medical schools in the
U.S., and in the top 15 percent (#27) of all 192 public and private
U.S. medical schools. The School of Medicine works locally,
nationally, and globally, with research and treatment facilities in
36 countries around the world.
Visit medschool.umaryland.edu.
This news release was issued on behalf of Newswise(TM). For more
information, visit http://www.newswise.com.
View original
content:https://www.prnewswire.com/news-releases/orthopaedic-surgeon-scientist-dr-frank-henn-named-chair-of-the-department-of-orthopaedics-302210888.html
SOURCE University of Maryland School of
Medicine